We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+12.21%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$53.1B
AUM Growth
+$4.7B
(+9.7%)
Cap. Flow
-$415M
Cap. Flow
% of AUM
-0.78%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
2,495
New
186
Increased
937
Reduced
1,188
Closed
172
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$144M |
| 2 |
NVIDIA
NVDA
|
+$137M |
| 3 |
GE Aerospace
GE
|
+$129M |
| 4 |
Dell
DELL
|
+$91.3M |
| 5 |
Comcast
CMCSA
|
+$88.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$103M |
| 2 |
Microchip Technology
MCHP
|
+$98.3M |
| 3 |
Steel Dynamics
STLD
|
+$87M |
| 4 |
UnitedHealth
UNH
|
+$79.5M |
| 5 |
Walmart Inc
WMT
|
+$79.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.58% |
| 2 | Consumer Discretionary | 13.58% |
| 3 | Healthcare | 12.97% |
| 4 | Financials | 12.15% |
| 5 | Industrials | 12.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PFC
901
DELISTED
Premier Financial Corp. Common Stock
PFC
| $5.57M | 0.01% |
231,265
-36,923
| -14% | -$729K |
|
902
First American
FAF
$7.32B
| $5.54M | 0.01% |
86,033
+27,628
| +47% | +$1.58M |
|
903
Omnicell
OMCL
$1.68B
| $5.53M | 0.01% |
147,039
+40,435
| +38% | +$1.49M |
|
904
DoorDash
DASH
$91.9B
| $5.51M | 0.01% |
55,681
+35,282
| +173% | +$3.12M |
|
905
BioMarin Pharmaceuticals
BMRN
$13.5B
| $5.5M | 0.01% |
57,073
-31,984
| -36% | -$2.83M |
|
906
Central Pacific Financial
CPF
$996M
| $5.5M | 0.01% |
279,529
-1,742
| -0.6% | -$30.5K |
|
907
M&T Bank
MTB
$36.4B
| $5.48M | 0.01% |
39,996
-18,103
| -31% | -$2.27M |
|
908
AngioDynamics
ANGO
$651M
| $5.44M | 0.01% |
694,226
+471,070
| +211% | +$3.27M |
|
909
Primerica
PRI
$9.63B
| $5.44M | 0.01% |
26,441
+4,318
| +20% | +$882K |
|
|
PETQ
910
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $5.43M | 0.01% |
275,141
+57,327
| +26% | +$1.1M |
|
911
Healthcare Services Group
HCSG
$1.44B
| $5.43M | 0.01% |
523,295
+106,185
| +25% | +$1.06M |
|
|
ANSS
912
DELISTED
Ansys
ANSS
| $5.42M | 0.01% |
14,944
-10,474
| -41% | -$3.1M |
|
913
Community Health Systems
CYH
$400M
| $5.42M | 0.01% |
1,732,367
+1,677,519
| +3,058% | +$4.52M |
|
914
Freshworks
FRSH
$3.31B
| $5.4M | 0.01% |
229,943
+153,565
| +201% | +$3.04M |
|
915
Voyager Therapeutics
VYGR
$197M
| $5.4M | 0.01% |
639,287
+440,465
| +222% | +$3.2M |
|
916
Newmont
NEM
$124B
| $5.38M | 0.01% |
130,086
-265,766
| -67% | -$10.3M |
|
917
Ziff Davis
ZD
$1.97B
| $5.38M | 0.01% |
80,003
-3,358
| -4% | -$213K |
|
918
American Eagle Outfitters
AEO
$2.91B
| $5.36M | 0.01% |
253,468
+109,264
| +76% | +$2.04M |
|
919
Constellation Energy
CEG
$98.6B
| $5.36M | 0.01% |
45,886
+11,496
| +33% | +$1.34M |
|
920
Warrior Met Coal
HCC
$5.16B
| $5.35M | 0.01% |
87,751
-54,108
| -38% | -$2.86M |
|
921
Watsco Inc
WSO
$13.2B
| $5.34M | 0.01% |
12,473
-391
| -3% | -$151K |
|
922
MaxLinear
MXL
$6.26B
| $5.32M | 0.01% |
224,006
+11,782
| +6% | +$231K |
|
923
Abercrombie & Fitch
ANF
$5.24B
| $5.29M | 0.01% |
59,999
+18,258
| +44% | +$1.3M |
|
924
Rivian
RIVN
$23.7B
| $5.29M | 0.01% |
225,575
+203,592
| +926% | +$3.83M |
|
925
Qiagen
QGEN
$8.81B
| $5.29M | 0.01% |
114,849
-76,689
| -40% | -$3.26M |
|
Similar funds
VGA
AQR Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, AQR Capital Management held 2,495 positions worth $53.1B, up 9.7% from $48.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
AQR Capital Management's Q4 2023 filing shows 186 new, 937 increased, 1,188 reduced and 172 closed positions. Its largest new stake was NCR Atleos: 518,383 shares worth $12.5M. The largest sale was Pfizer, an estimated $103M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- AQR Capital Management's largest Q4 2023 buy was NCR Atleos: 518,383 shares worth $12.5M.
- AQR Capital Management added most to Amazon in Q4 2023, an estimated $144M increase.
- AQR Capital Management's biggest Q4 2023 reduction was Pfizer, cutting an estimated $103M.
- AQR Capital Management fully exited Activision Blizzard in Q4 2023, selling an estimated $38.5M.
- AQR Capital Management's ten largest holdings make up 15% of its $53.1B portfolio in Q4 2023.
- AQR Capital Management opened 186 new positions and closed 172 in Q4 2023.
- AQR Capital Management's portfolio value rose 9.7% quarter-over-quarter to $53.1B.
Based on AQR Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.